Koncentrace hepatocytárního růstového faktoru a trombospondinu predikuje léčebnou odpověď u pacientů s mnohočetným myelomem

• Title in English: Concentration of hepatocyte growth factor and thrombospondin predict treatment response in patients with multiple myeloma
• Authors: ŠVÁCHOVÁ Hana; POUR Luděk; ALMÁŠI Martina; NĚMEC Pavel; KRÁLOVÁ Dana; KOVÁŘOVÁ Lucie; PENKA Miroslav; VORLÍČEK Jiří; HÁJEK Roman
• Year of publication: 2010
• Type: Article in Periodical
• Magazine / Source: Transfuze a hematologie dnes
• MU Faculty or unit: Faculty of Medicine
• Field: Oncology and hematology
• Keywords: multiple myeloma; angiogenesis; HGF; thrombospondin; bortezomib
• Description: Multiple myeloma is hematological malignancy in which has been demonstrated increased level of angiogenesis. We ratified hypothesis that high levels of thrombospondin and low levels of HGF correlate with a good response after bortezomib treatment.

Related projects

• University Research Centre - Czech Myeloma Group
• From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies